National Health Investors (NYSE:NHI) Sets New 12-Month High at $62.31

National Health Investors, Inc. (NYSE:NHI) shares reached a new 52-week high on Thursday . The stock traded as high as $62.31 and last traded at $62.02, with a volume of 4189 shares traded. The stock had previously closed at $61.82.

Analyst Ratings Changes

Several research firms recently issued reports on NHI. StockNews.com upgraded National Health Investors from a “hold” rating to a “buy” rating in a report on Monday. Deutsche Bank Aktiengesellschaft assumed coverage on National Health Investors in a research report on Tuesday, January 30th. They set a “buy” rating and a $69.00 price target for the company. Wedbush raised their price objective on National Health Investors from $64.00 to $66.00 and gave the company an “outperform” rating in a report on Monday, March 18th. BMO Capital Markets upgraded shares of National Health Investors from a “market perform” rating to an “outperform” rating and set a $67.00 target price for the company in a research report on Tuesday, March 12th. Finally, Wells Fargo & Company raised shares of National Health Investors from an “equal weight” rating to an “overweight” rating and raised their price target for the stock from $55.00 to $63.00 in a research note on Monday, February 26th. Four analysts have rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $59.22.

National Health Investors Stock Performance

The firm has a market cap of $2.71 billion, a PE ratio of 19.75 and a beta of 0.94. The company has a debt-to-equity ratio of 0.90, a quick ratio of 10.27 and a current ratio of 10.27. The firm’s 50 day moving average price is $56.58 and its two-hundred day moving average price is $54.23.

National Health Investors Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, May 3rd. Shareholders of record on Thursday, March 28th will be given a $0.90 dividend. The ex-dividend date of this dividend is Wednesday, March 27th. This represents a $3.60 dividend on an annualized basis and a yield of 5.76%. National Health Investors’s payout ratio is currently 115.02%.

Insider Buying and Selling at National Health Investors

In related news, Director Charlotte A. Swafford bought 10,000 shares of the company’s stock in a transaction that occurred on Tuesday, February 27th. The stock was purchased at an average price of $58.69 per share, for a total transaction of $586,900.00. Following the acquisition, the director now owns 110,185 shares of the company’s stock, valued at $6,466,757.65. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Company insiders own 7.26% of the company’s stock.

Institutional Trading of National Health Investors

Several hedge funds have recently made changes to their positions in NHI. Vanguard Group Inc. increased its position in shares of National Health Investors by 1.0% during the first quarter. Vanguard Group Inc. now owns 6,404,110 shares of the real estate investment trust’s stock worth $377,907,000 after acquiring an additional 60,990 shares during the period. BlackRock Inc. raised its position in National Health Investors by 1.3% in the 2nd quarter. BlackRock Inc. now owns 4,220,046 shares of the real estate investment trust’s stock valued at $221,215,000 after purchasing an additional 54,952 shares in the last quarter. State Street Corp boosted its stake in shares of National Health Investors by 0.3% in the 2nd quarter. State Street Corp now owns 2,191,956 shares of the real estate investment trust’s stock valued at $134,749,000 after buying an additional 5,762 shares during the period. Principal Financial Group Inc. boosted its stake in shares of National Health Investors by 8.5% in the 4th quarter. Principal Financial Group Inc. now owns 1,870,632 shares of the real estate investment trust’s stock valued at $104,475,000 after buying an additional 146,735 shares during the period. Finally, Geode Capital Management LLC grew its position in shares of National Health Investors by 1.5% during the second quarter. Geode Capital Management LLC now owns 933,049 shares of the real estate investment trust’s stock worth $48,910,000 after buying an additional 13,654 shares in the last quarter. Institutional investors and hedge funds own 62.51% of the company’s stock.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.